XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Stockholders' (Deficit) - USD ($)
$ in Thousands
Common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total
Balance (in shares) at Dec. 31, 2023 75,708,889        
Balance at the beginning of the period at Dec. 31, 2023 $ 75 $ 2,466,233 $ (1,285) $ (3,283,578) $ (818,555)
Increase (Decrease) in Stockholders' Equity          
Exercise of options (in shares) 109,892        
Exercise of options   2,030     2,030
Restricted stock vesting and issuance (in shares) 835,179        
Restricted stock vesting and issuance, net $ 1       1
Share-based compensation expense   18,378     18,378
Receivable from investor   81     81
Net Income (Loss)       (91,576) (91,576)
Comprehensive income (loss)     (4,275)   (4,275)
Balance (in shares) at Mar. 31, 2024 76,653,960        
Balance at the end of the period at Mar. 31, 2024 $ 76 2,486,722 (5,560) (3,375,154) (893,916)
Balance (in shares) at Dec. 31, 2024 77,704,188        
Balance at the beginning of the period at Dec. 31, 2024 $ 77 2,574,611 (25,886) (3,646,873) (1,098,071)
Increase (Decrease) in Stockholders' Equity          
Exercise of options (in shares) 431,089        
Exercise of options   15,751     15,751
Restricted stock vesting and issuance (in shares) 1,089,999        
Restricted stock vesting and issuance, net $ 1       1
Share-based compensation expense   18,060     18,060
Net Income (Loss)       866,562 866,562
Comprehensive income (loss)     11,937   11,937
Balance (in shares) at Mar. 31, 2025 79,225,276        
Balance at the end of the period at Mar. 31, 2025 $ 78 $ 2,608,422 $ (13,949) $ (2,780,311) $ (185,760)